Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › WA › Pasco › NPI 1831284280
Hospital

Lourdes Hospital LLC

Lourdes Hospital LLC was paid $33.94M by Medicaid between Jan 2018 and Dec 2024, across 262 billing codes. Its largest line is 99283, emergency room visit (moderate) — 20% of everything it billed.

33Billing provider infoLOURDES HOSPITAL LLC
PASCO, WA 99301
33aNPI1831284280assigned 10/03/2006
33bProvider typeCritical Access Hospital
28Total paid$33.94M
24GClaims601,920
24DCodes billed262
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers

Next to other Critical Access Hospital providers in Washington

Rank by total paid#4 of 30
Median peer was paid$9.10M
This provider vs. median3.7×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Auditor's notes

Automated statistical signals. Not evidence of fraud — how these are computed.

Entity ProliferationAuthorized official LAWRENCE, CHARLOTTE controls 20+ related entities in our dataset. Read more
Box 24A · Dates of service

Paid by month

$0$200K$400K$600K2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
201893,166$5.27M
201978,684$4.34M
202062,941$3.73M
202190,882$4.80M
2022101,173$5.32M
202398,664$5.32M
2024incomplete76,410$5.16M
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
99283 Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity 20% 42,470 38,636 $6.68M
99284 Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity 17% 24,361 20,737 $5.62M
99285 Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life 15% 12,915 11,002 $5.12M
74177 Computed tomography, abdomen and pelvis; with contrast material 6.9% 3,535 3,238 $2.36M
97110 Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion 3.4% 23,243 6,490 $1.15M
80053 Comprehensive metabolic panel 2.6% 32,534 27,543 $888K
97140 Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) 2.3% 13,761 4,486 $771K
85025 Blood count; complete (CBC), automated, and automated differential WBC count 1.8% 35,328 29,300 $602K
70450 Computed tomography, head or brain; without contrast material 1.7% 3,200 2,923 $575K
93005 Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report 1.5% 13,075 11,334 $518K
99282 Emergency department visit for the evaluation and management, low to moderate severity 1.4% 5,419 5,098 $485K
74176 Computed tomography, abdomen and pelvis; without contrast material 1.4% 938 872 $481K
250 more codes
76705 Ultrasound, abdominal, real time with image documentation; limited 1.1% 2,897 $357K
G0378 Hospital observation service, per hour 1.0% 865 $349K
97112 Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination <1% 5,847 $285K
71045 Radiologic examination, chest; single view <1% 8,220 $277K
96374 Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance <1% 16,013 $267K
81001 <1% 14,753 $244K
88305 Level IV - Surgical pathology, gross and microscopic examination <1% 1,905 $237K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular <1% 6,086 $207K
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r <1% 5,176 $198K
84484 <1% 8,707 $195K
96361 Intravenous infusion, hydration; each additional hour <1% 12,597 $194K
71046 Radiologic examination, chest; 2 views <1% 3,815 $189K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay <1% 2,261 $180K
93306 Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete <1% 962 $177K
72125 Computed tomography, cervical spine; without contrast material <1% 611 $169K
76830 Ultrasound, transvaginal <1% 1,538 $165K
87086 Culture, bacterial; quantitative colony count, urine <1% 5,821 $156K
99281 Emergency department visit for the evaluation and management, self-limited or minor <1% 4,688 $149K
77067 Screening mammography, bilateral, including computer-aided detection <1% 2,224 $142K
83690 <1% 8,251 $138K
36415 Collection of venous blood by venipuncture <1% 38,153 $135K
84443 Thyroid stimulating hormone (TSH) <1% 4,575 $121K
87081 <1% 3,194 $105K
96365 Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour <1% 3,343 $103K
96360 Intravenous infusion, hydration; initial, 31 minutes to 1 hour <1% 3,858 $101K
80061 Lipid panel <1% 2,947 $101K
80306 <1% 2,269 $100K
87804 Infectious agent antigen detection by immunoassay; Influenza, each type <1% 2,709 $97K
81025 <1% 6,021 $96K
87040 <1% 1,439 $90K
74018 <1% 2,000 $86K
86140 <1% 5,859 $84K
43239 Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple <1% 188 $82K
45385 Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) <1% 110 $82K
96375 Therapeutic injection; each additional sequential IV push <1% 10,347 $81K
71250 <1% 365 $77K
45378 Colonoscopy, flexible; diagnostic, including collection of specimen(s) <1% 103 $74K
83605 <1% 2,408 $72K
94761 <1% 3,443 $72K
83036 Hemoglobin; glycosylated (A1C) <1% 2,724 $72K
80048 Basic metabolic panel (calcium, ionized) <1% 3,765 $71K
94640 Pressurized or nonpressurized inhalation treatment for acute airway obstruction <1% 2,125 $70K
84702 <1% 1,757 $68K
76770 <1% 368 $67K
83735 <1% 2,445 $64K
87400 <1% 678 $63K
76805 Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation <1% 432 $62K
87651 Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe <1% 1,832 $53K
87880 Infectious agent antigen detection by immunoassay; Streptococcus, group A <1% 2,129 $52K
73562 <1% 1,091 $51K
85652 <1% 4,718 $49K
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed <1% 2,810 $45K
99214 Doctor's office visit, returning patient (more involved) <1% 10,752 $44K
73610 <1% 973 $43K
J3490 Unclassified drugs <1% 3,502 $42K
97162 <1% 521 $40K
73030 <1% 962 $39K
81003 <1% 3,127 $39K
80305 <1% 928 $39K
97530 Therapeutic activities, direct patient contact, each 15 minutes <1% 537 $38K
J0696 Injection, ceftriaxone sodium, per 250 mg <1% 2,336 $38K
85610 <1% 2,867 $37K
97014 <1% 4,556 $36K
73130 <1% 1,267 $34K
87637 Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV <1% 949 $34K
71275 Computed tomographic angiography, chest, with contrast material <1% 77 $34K
76856 Ultrasound, pelvic (nonobstetric), real time with image documentation; complete <1% 270 $34K
72100 <1% 776 $32K
J1885 Injection, ketorolac tromethamine, per 15 mg <1% 5,452 $31K
82948 <1% 3,761 $31K
87186 <1% 1,165 $30K
95886 <1% 774 $30K
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe <1% 581 $29K
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe <1% 579 $28K
73630 <1% 763 $26K
76801 <1% 186 $26K
83880 <1% 1,467 $25K
84436 <1% 1,158 $25K
95810 Polysomnography; sleep staging with 4 or more additional parameters <1% 44 $25K
83550 <1% 918 $25K
C9803 Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source <1% 2,768 $24K
86850 <1% 1,610 $23K
85730 <1% 1,549 $23K
99211 Office or other outpatient visit for the evaluation and management of an established patient, minimal severity <1% 3,674 $23K
82570 <1% 508 $22K
J2405 Injection, ondansetron hydrochloride, per 1 mg <1% 8,414 $22K
96376 <1% 3,333 $22K
86756 <1% 262 $21K
99213 Doctor's office visit, returning patient (routine) <1% 6,094 $21K
84479 <1% 1,101 $20K
S9485 Crisis intervention mental health services, per diem <1% 91 $20K
94664 <1% 1,389 $19K
97161 <1% 284 $19K
77063 Screening digital breast tomosynthesis, bilateral <1% 2,050 $19K
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml <1% 2,029 $18K
85379 <1% 730 $18K
83540 <1% 639 $18K
J2704 Injection, propofol, 10 mg <1% 2,915 $17K
12001 <1% 231 $17K
76700 Ultrasound, abdominal, real time with image documentation; complete <1% 104 $17K
J0690 Injection, cefazolin sodium, 500 mg <1% 1,186 $17K
86003 <1% 85 $16K
82728 <1% 767 $16K
71260 Computed tomography, thorax, diagnostic; with contrast material <1% 45 $16K
93041 <1% 684 $15K
87088 <1% 990 $15K
88304 <1% 304 $14K
86900 <1% 1,961 $13K
85027 <1% 1,190 $13K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe <1% 515 $13K
87340 <1% 407 $12K
96366 Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour <1% 353 $12K
76641 <1% 84 $11K
J0561 Injection, penicillin g benzathine, 100,000 units <1% 122 $11K
85007 <1% 1,241 $11K
J1100 Injection, dexamethasone sodium phosphate, 1 mg <1% 3,388 $11K
87389 Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies <1% 469 $11K
73140 <1% 437 $10K
H2036 Alcohol and/or other drug treatment program, per diem <1% 91 $10K
76642 <1% 227 $10K
87641 <1% 350 $10K
J1170 Injection, hydromorphone, up to 4 mg <1% 3,715 $9K
G0383 Level 4 hospital emergency department visit provided in a type b emergency department; (the ed must meet at least one of the following requirements: (1) it is licensed by the state in which it is located under applicable state law as an emergency room or emergency department; (2) it is held out to the public (by name, posted signs, advertising, or other means) as a place that provides care for emergency medical conditions on an urgent basis without requiring a previously scheduled appointment; or (3) during the calendar year immediately preceding the calendar year in which a determination under 42 cfr 489.24 is being made, based on a representative sample of patient visits that occurred during that calendar year, it provides at least one-third of all of its outpatient visits for the treatment of emergency medical conditions on an urgent basis without requiring a previously scheduled appointment) <1% 230 $9K
82043 <1% 306 $9K
86780 <1% 173 $9K
86901 <1% 1,960 $9K
73110 <1% 268 $8K
82550 <1% 512 $8K
82607 <1% 282 $7K
J3010 Injection, fentanyl citrate, 0.1 mg <1% 2,752 $7K
J2250 Injection, midazolam hydrochloride, per 1 mg <1% 2,057 $7K
87077 <1% 331 $7K
93971 <1% 47 $6K
82306 Vitamin D; 25 hydroxy, includes fraction(s), if performed <1% 598 $6K
J2060 Injection, lorazepam, 2 mg <1% 2,175 $6K
82803 <1% 134 $6K
76870 <1% 40 $6K
J2930 Injection, methylprednisolone sodium succinate, up to 125 mg <1% 660 $5K
73502 <1% 124 $5K
99204 Doctor's office visit, new patient (more involved) <1% 1,790 $5K
90715 <1% 358 $5K
83655 <1% 319 $5K
45380 Colonoscopy, flexible; with biopsy, single or multiple <1% 29 $5K
J2543 Injection, piperacillin sodium/tazobactam sodium, 1 gram/0.125 grams (1.125 grams) <1% 153 $5K
95909 <1% 60 $5K
86480 <1% 125 $4K
86803 <1% 78 $4K
87420 <1% 147 $4K
94060 <1% 80 $4K
84703 <1% 255 $4K
U0005 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 <1% 2,983 $4K
84439 <1% 134 $4K
J1200 Injection, diphenhydramine hcl, up to 50 mg <1% 1,250 $3K
72040 <1% 68 $3K
82746 <1% 141 $3K
86022 <1% 14 $3K
72131 <1% 12 $3K
73120 <1% 122 $3K
73080 <1% 66 $3K
76000 <1% 27 $3K
93010 Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only <1% 4,294 $3K
76536 <1% 25 $3K
93017 <1% 24 $3K
99215 Doctor's office visit, returning patient (complex) <1% 879 $3K
J2270 Injection, morphine sulfate, up to 10 mg <1% 954 $3K
80074 <1% 63 $2K
J2550 Injection, promethazine hcl, up to 50 mg <1% 811 $2K
95908 <1% 34 $2K
90471 Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine <1% 746 $2K
80179 <1% 141 $2K
85008 <1% 148 $2K
80143 <1% 138 $2K
97163 <1% 27 $2K
J2795 Injection, ropivacaine hydrochloride, 1 mg <1% 213 $2K
73560 <1% 53 $2K
82310 <1% 242 $2K
87633 Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets <1% 15 $1K
73620 <1% 58 $1K
J1815 Injection, insulin, per 5 units <1% 118 $1K
J2919 Injection, methylprednisolone sodium succinate, 5 mg <1% 137 $1K
80047 <1% 40 $980.13
97803 <1% 30 $959.53
86038 <1% 44 $953.05
99203 Doctor's office visit, new patient (routine) <1% 409 $913.88
J0171 Injection, adrenalin, epinephrine, 0.1 mg <1% 47 $904.30
86708 <1% 30 $844.13
51798 <1% 85 $754.08
51702 <1% 33 $724.53
J2765 Injection, metoclopramide hcl, up to 10 mg <1% 223 $717.79
80076 <1% 19 $689.30
82248 <1% 59 $671.66
99212 Office or other outpatient visit for the evaluation and management of an established patient, straightforward <1% 88 $646.76
86706 <1% 30 $644.04
83516 <1% 13 $608.74
36000 <1% 66 $601.50
J3480 Injection, potassium chloride, per 2 meq <1% 21 $548.60
84153 <1% 13 $539.31
J3475 Injection, magnesium sulfate, per 500 mg <1% 27 $503.75
29125 <1% 13 $503.44
77065 Tomosynthesis, mammo <1% 14 $445.04
A4216 Sterile water, saline and/or dextrose, diluent/flush, 10 ml <1% 1,604 $436.64
82247 <1% 37 $433.57
51701 <1% 16 $428.67
87070 <1% 12 $401.82
82947 <1% 23 $401.77
A4565 Slings <1% 53 $398.17
82785 <1% 12 $394.96
87205 <1% 27 $380.56
86709 <1% 13 $373.73
86704 <1% 15 $292.42
99205 Prolong outpt/office vis <1% 121 $256.10
J0131 Injection, acetaminophen, not otherwise specified,10 mg <1% 19 $253.26
A6449 Light compression bandage, elastic, knitted/woven, width greater than or equal to three inches and less than five inches, per yard <1% 247 $247.00
97016 <1% 42 $230.44
J1171 Injection, hydromorphone, 0.1 mg <1% 69 $223.39
J0780 Injection, prochlorperazine, up to 10 mg <1% 12 $177.22
99202 Office or other outpatient visit for the evaluation and management of a new patient, straightforward <1% 35 $171.55
A4556 Electrodes, (e.g., apnea monitor), per pair <1% 216 $168.90
0002A <1% 21 $144.54
87798 Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism <1% 15 $108.66
87581 <1% 15 $108.66
87486 <1% 15 $108.66
J2710 Injection, neostigmine methylsulfate, up to 0.5 mg <1% 47 $107.01
0001A <1% 13 $96.76
84403 <1% 13 $95.20
A9270 Non-covered item or service <1% 6,316 $64.07
90656 <1% 23 $60.59
80320 <1% 1,007 $60.32
J1940 Injection, furosemide, up to 20 mg <1% 35 $51.28
J1650 Injection, enoxaparin sodium, 10 mg <1% 21 $45.66
81002 <1% 238 $34.12
96127 <1% 81 $20.05
3077F 0% 57 $0.00
91300 0% 34 $0.00
1160F 0% 983 $0.00
3725F 0% 411 $0.00
3078F 0% 634 $0.00
G8978 Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals 0% 43 $0.00
0502F 0% 13 $0.00
G8979 Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting 0% 93 $0.00
G0283 Electrical stimulation (unattended), to one or more areas for indication(s) other than wound care, as part of a therapy plan of care 0% 720 $0.00
80329 0% 524 $0.00
1125F 0% 251 $0.00
1036F 0% 789 $0.00
3074F 0% 526 $0.00
3008F 0% 874 $0.00
G0008 Administration of influenza virus vaccine 0% 14 $0.00
3079F 0% 59 $0.00
1126F 0% 310 $0.00
3075F 0% 13 $0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialLAWRENCE, CHARLOTTE (SECRETARY)
Same official

Other billing entities under LAWRENCE, CHARLOTTE

Full network →
ProviderLocationPaid
Lake Cumberland Regional Hospital LLCSomerset, KY$77.77M
Danville Regional Medical Center, LLCDanville, VA$65.11M
Phc-Las Cruces INCLas Cruces, NM$64.77M
Georgetown Community Hospital LLCGeorgetown, KY$44.03M
Pinelake Regional Hospital LLCMayfield, KY$43.34M
Raleigh General Hospital LLCBeckley, WV$36.44M
Rchp-Sierra Vista INCSierra Vista, AZ$29.77M
Clinch Valley Medical Center INC.Richlands, VA$26.28M
Spring View Hospital LLCLebanon, KY$23.35M
Havasu Regional Medical Center LLCLake Havasu City, AZ$23.19M
Las Cruces Physician Practices, LLCLas Cruces, NM$22.78M
Meadowview Regional Medical Center LLCMaysville, KY$22.57M
Lourdes Hospital LLCRichland, WA$22.38M
Danville Regional Medical Center LLCMartinsville, VA$21.09M
Phc-Fort Mohave INCFort Mohave, AZ$19.95M
Wythe County Community Hospital LLCWytheville, VA$18.30M
DLP Conemaugh Memorial Medical Center LLCJohnstown, PA$18.22M
Bourbon Community Hospital LLCParis, KY$18.14M
Willamette Valley Medical Center LLCMcminnville, OR$17.29M
Lake Cumberland Regional Hospital, LLCSomerset, KY$15.55M

Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.